Related Experiment Videos
Dose-intensive chemotherapy in breast cancer--the need for appropriate measures of outcome
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
ApoAI-phosphatidylcholine infusion neutralizes the atherothrombotic effects of C-reactive protein in humans.
Journal of thrombosis and haemostasis : JTH·2008
Thrombopoietin: an update on therapeutic potential.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia.
Annals of oncology : official journal of the European Society for Medical Oncology·2002
Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents.
International journal of hematology·2002
Pharmacokinetic analysis of pegylated megakaryocyte growth and development factor in humans.
Growth factors (Chur, Switzerland)·2001
Sofetabart mipitecan, an antibody drug conjugate targeting folate receptor alpha, in high grade ovarian cancer: Results from the first-in-human phase 1 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Efficacy of Cryotherapy in Preventing Taxane-Induced Neuropathy: The CryoPac Randomised Controlled Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final results and predictive biomarkers of response and long-term outcomes with first-line pembrolizumab monotherapy in advanced renal cell carcinoma in the phase II KEYNOTE-427 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Navigating uncertainties and evidence gaps in adjuvant therapy for premenopausal women with HR+/HER2- breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase Ib study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026